DGHRI Seminar Series: “The Non-Traditional Contributors to the Global Burden of Cardiovascular Disease”
In partnership with Africa and Middle East Congress on Addiction (AMECA), the Duluth Global Health Research Institute (DGHRI) presents its upcoming monthly seminar series!
This month we welcome Katie Benziger, MD, MPH, FAHA, FACC, Medical Director, Heart and Vascular Research, Assistant Professor, University of Minnesota Medical School, Non-invasive cardiologist, Essentia Health Heart and Vascular Center, as she presents results from the GBD (Global Burden of Disease) study focusing on cardiovascular diseases – “The Non-Traditional Contributors to the Global Burden of Cardiovascular Disease.”
“The Non-Traditional Contributors to the Global Burden of Cardiovascular Disease.”
Hosted by: Department Head, Peter Nalin, MD, MBA, FAAFP
WHEN: Tuesday, November 30, 2021
TIME: 3:00 to 4:00 pm (GMT); 10:00 am central US time
REGISTER!
Dr. Benziger will talk through the results from the GBD (Global Burden of Disease) study focusing on cardiovascular diseases, which account for about one-half of all non-communicable disease deaths. The presentation will focus on the rise of non-communicable diseases in low- and middle-income countries and will highlight the role of traditional risk factors, like tobacco smoking, high blood pressure, and unhealthful diet as well as the nontraditional risk factors like air pollution, human immunodeficiency virus (HIV), and unhealthful alcohol consumption.
Dr. Katie Benziger is the medical director of research at Essentia Health Heart and Vascular Center and an adjunct assistant professor at the University of Minnesota Medical School, Duluth campus. Dr. Benziger earned a bachelor’s of arts with honors at Macalester College in St. Paul, MN. She received her medical degree from the University of Minnesota. Subsequently, she completed her residency training and cardiology fellowship training at the University of Washington where she also completed her Masters of Public Health in the Health Metrics and Evaluation track.
Dr. Benziger has participated in many clinical trials. She is an active and productive researcher with many publications related to risk factors for cardiovascular diseases. She has presided over the Heart and Vascular research program since her arrival in 2017. She is an active member of the American Heart Association (AHA) and speaks at local Go Red for Women events promoting women’s cardiovascular disease as well as sits on a number of national AHA Epidemiology committees.
